Dercum’s Disease Market Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospital & Clinics, Others) - Forecast Till 2027
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Dercum’s Disease Market, by Treatment
6.1 Introduction
6.2 Surgery
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3 Medication
6.3.1 Diuretics
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.2 Non-Steroidal Anti-Inflammatory Drugs
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.3 Corticosteroids
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.3.4 Others
6.4 Liposuction
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.5 Electrotherapy
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.6 Acupuncture
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
6.7 Others
Chapter 7. Global Dercum’s Disease Market, by Distribution Channel
7.1 Introduction
7.2 Retail Pharmacies
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
7.3 Hospital Pharmacies
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
7.4 Others
Chapter 8. Global Dercum’s Disease Market, by End-User
8.1 Introduction
8.2 Hospital & Clinics
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
8.3 Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2019–2027
Market Estimates & Forecast, by Country, 2019–2027
8.4 Others
Chapter 9. Global Dercum’s Disease Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Pfizer, Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 AbbVie, Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Johnson & Johnson Services, Inc.
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Novartis
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Acorda Therapeutics, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 F. Hoffman La Roche AG
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Eli Lily and Company
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 AstraZeneca Plc
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Amgen
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Valeant Pharmaceuticals
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Syneron Medical
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 St. Jude Medical Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Alimed Inc.
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Dercum’s Disease Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Dercum’s Disease Market Synopsis, 2019–2027
Table 2 Global Dercum’s Disease Market Estimates and Forecast, 2019–2027 (USD Million)
Table 3 Global Dercum’s Disease Market, by Region, 2019–2027 (USD Million)
Table 4 Global Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 5 Global Dercum’s Disease Market, by Distribution Channel, 2019–2027(USD Million)
Table 6 Global Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)
Table 7 North America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 8 North America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD
Million)
Table 9 North America: Dercum’s Disease Market, by End-User, 2019–2027 (USD
Million)
Table 10 US: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 11 US: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)
Table 12 US: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)
Table 13 Canada: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 14 Canada: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)
Table 15 Canada: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)
Table 16 South America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 17 South America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD
Million)
Table 18 South America: Dercum’s Disease Market, by End-User, 2019–2027 (USD
Million)
Table 19 Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 20 Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)
Table 21 Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)
Table 22 Western Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 23 Western Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD
Million)
Table 24 Western Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD
Million)
Table 25 Eastern Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 26 Eastern Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD
Million)
Table 27 Eastern Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD
Million)
Table 28 Asia-Pacific: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)
Table 29 Asia-Pacific: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD
Million)
Table 30 Asia-Pacific: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)
Table 31 Middle East & Africa: Dercum’s Disease Market, by Treatment, 2019–2027
(USD Million)
Table 32 Middle East & Africa: Dercum’s Disease Market, by Distribution Channel, 2019–2027
(USD Million)
Table 33 Middle East & Africa: Dercum’s Disease Market, by End-User, 2019–2027
(USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Dercum’s Disease Market
Figure 3 Segmentation Market Dynamics for Global Dercum’s Disease Market
Figure 4 Global Dercum’s Disease Market Share, by Treatment, 2019
Figure 5 Global Dercum’s Disease Market Share, by Distribution Channel, 2019
Figure 6 Global Dercum’s Disease Market Share, by End-User, 2019
Figure 7 Global Dercum’s Disease Market Share, by Region, 2019
Figure 8 North America: Dercum’s Disease Market Share, by Country, 2019
Figure 9 Europe: Dercum’s Disease Market Share, by Country, 2019
Figure 10 Asia-Pacific: Dercum’s Disease Market Share, by Country, 2019
Figure 11 Middle East & Africa: Dercum’s Disease Market Share, by Country, 2019
Figure 12 Global Dercum’s Disease Market: Company Share Analysis, 2019 (%)
Figure 13 Pfizer, Inc.: Key Financials
Figure 14 Pfizer, Inc.: Segmental Revenue
Figure 15 Pfizer, Inc.: Geographical Revenue
Figure 16 AbbVie, Inc.: Key Financials
Figure 17 AbbVie, Inc.: Segmental Revenue
Figure 18 AbbVie, Inc.: Geographical Revenue
Figure 19 Merck & Co., Inc.: Key Financials
Figure 20 Merck & Co., Inc.: Segmental Revenue
Figure 21 Merck & Co., Inc.: Geographical Revenue
Figure 22 Johnson & Johnson Services, Inc.: Key Financials
Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 25 GlaxoSmithKline plc: Key Financials
Figure 26 GlaxoSmithKline plc: Segmental Revenue
Figure 27 GlaxoSmithKline Plc. Geographical Revenue
Figure 28 Novartis: Key Financials
Figure 29 Novartis: Segmental Revenue
Figure 30 Novartis: Geographical Revenue
Figure 31 Acorda Therapeutics, Inc.: Key Financials
Figure 32 Acorda Therapeutics, Inc.: Segmental Revenue
Figure 33 Acorda Therapeutics, Inc.: Geographical Revenue
Figure 34 F. Hoffman La Roche AG: Key Financials
Figure 35 F. Hoffman La Roche AG: Segmental Revenue
Figure 36 F. Hoffman La Roche AG: Geographical Revenue
Figure 37 Eli Lily and Company: Key Financials
Figure 38 Eli Lily and Company: Segmental Revenue
Figure 39 Eli Lily and Company: Geographical Revenue
Figure 40 AstraZeneca Plc: Key Financials
Figure 41 AstraZeneca Plc: Segmental Revenue
Figure 42 AstraZeneca Plc: Geographical Revenue
Figure 43 Amgen: Key Financials
Figure 44 Amgen: Segmental Revenue
Figure 45 Amgen: Geographical Revenue
Figure 43 Valeant Pharmaceuticals: Key Financials
Figure 44 Valeant Pharmaceuticals: Segmental Revenue
Figure 45 Valeant Pharmaceuticals: Geographical Revenue
Figure 46 Syneron Medical: Key Financials
Figure 47 Syneron Medical: Segmental Revenue
Figure 48 Syneron Medical: Geographical Revenue
Figure 49 St. Jude Medical Inc.: Key Financials
Figure 50 St. Jude Medical Inc.: Segmental Revenue
Figure 51 St. Jude Medical Inc.: Geographical Revenue
Figure 52 Alimed, Inc.: Key Financials
Figure 53 Alimed, Inc.: Segmental Revenue
Figure 54 Alimed, Inc.: Geographical Revenue
Speak to Analyst
Request a Free Sample
Decrum's Disease Market Overview:
The decrum's disease market is one of the rapidly improving market structures which is projected to achieve better future results due to the rising number of cases of decrum's disease surgeries which leads to continuous investments being made towards the establishment and growth of the healthcare sector and the treatment services to overcome decrum's disease.
Decrum’s disease which is also known as adipose Dolorosa is a temporary physical disability that affects the lipomas in the body and is often observed as painful growth of the tissues that causes pain in the upper arms and upper legs of the patient. It is observed that it commonly affects women and that too it is very hard to find a treatment for the disease. However, continuous research is being carried on in the healthcare sector to find a permanent solution to this problem.
The basic decrum’s disease symptoms that are common to be found are weight gain, swelling in body parts, depressions, difficulty in sleeping, fatigue, weakness, shortage of breath, rapid heart rate, and others which provide clear signs that a person might be suffering from the disease and hence needs treatment for decrum’s disease. The continuous advancement in technology and rapid globalization in the health sector has provided a boost to the global decrum’s disease market in finding out treatment for the disease.
The global decrum's disease market is expected to grow at a CAGR of around 7.1%. The decrum's disease market is expected to reap positive results from the Asia Pacific region where the continuous research and development processes and increased expenditure on the healthcare sector have boosted the growth of treatment of decrum’s disease. Moreover, the segment by end-user is expected to contribute maximum towards decrum's disease treatment market share.
COVID 19 Analysis of Decrum's Disease Market:
The novel coronavirus or the Covid 19 pandemic has negatively impacted the decrum's disease industry since the rising number of decrum's disease cases have been affected since the healthcare service providers and frontline workers are focussed more on handling the upcoming covid cases which have reduced the significant consideration being paid to the decorum’s disease. Due to the lockdowns in various countries, the demand for treatment of decrum's disease has significantly reduced due to restriction of people in moving freely and also people avoiding much of their visits to the health care places until there’s an emergency. Due to the Covid 19 effect, it has been observed that a large number of companies are forced to lay off employees but it is assumed that the market will soon pick up the pace and the demand would increase. It is expected that the post-lockdown period would be a great success for the treatment of decorum’s disease since more stress would be laid on research and samples to be collected. It is also analyzed that every segment would be contributing significantly towards the growth of decrum's disease treatment market value.
Decrum's Disease Market Dynamics
Drivers:
The decrum's disease market has been experiencing a diversified growth in all segments and across different regions due to the rising populations and the increasing per capita incomes of people which has shifted the demands of people to highly sophisticated and technologically advanced products and equipment which have acted as a motivating factor to the decrum's disease market.
Secondly, the growing cases of lipomas have acted as a major key driver since the reporting of decrum’s disease cases have increased in the past decade especially among women which have provided a roadway to the global health care companies to find treatment for decrum’s disease. The increased research and development in the treatment for decrum’s disease have contributed towards the growth of decrum's disease market.
Another major driver in the global decrum's disease market has been the ever-increasing health awareness programs and missions which have motivated people all over the world towards improvement in their health stats and to also be aware of the diseases that can be caused due to the consumption of various products. Also, the improvement in health care facilities all around the world has facilitated the decrum's disease market to have a vast growth.
Restraints:
The overall growth in the decrum's disease market has been expediently rising but certain factors hinder the growth process of the market which include large sums of money to be invested initially in setting up of decrum's disease treatment and medicinal companies and thus it restricts various new players to enter the decrum's disease markets.
Another key factor that acts as a barrier towards an increase in decrum's disease treatment market share is the lack of awareness among the people about the disease. In western countries, people are becoming aware of the disease but in developing nations, people are unaware of the disease which is a major threat to the market. Also, the symptoms are too common for people to realize the urgency of the situation for the treatment of disease.
Another key restraint that has been observed off late is the high cost of the decrum's disease treatment which bars most of the patients who are not aptly equipped with all the financial resources and also affects the decrum's disease treatment market share since it cannot cater to the diverse variety of patients of different sections of the society.
Technology Analysis:
The decrum's disease market trends have been dedicated towards the use of improved technology in the treatment process since the procedure for decrum's disease treatment is based on highly scientific procedures and methods, it is usually carried on with the help of advanced tools and machines.
However, to be more specific, decrum's disease procedure involves the use of biopsy in the initial stages to understand the condition of the lipomas after which the diagnosis process is established which involves the liposuction technique, electrotherapy technique, and the acupuncture technique to provide a cure for the decrum’s disease. Thus, the technical aspects in the treatment of decrum’s disease have played a vital role in the growth of the market and are also being continuously developed.
The technological system to be used in the near future in the decrum's disease treatment market involves using robotics and the artificial intelligence systems to provide for the specific and timely location of cancer and then proceed with the treatment process and to remove the fatty tissues by minimizing every threat associated with the treatment and also ensuring that the decrum’s disease does not reoccur.
Study Objectives:
- To analyze the trends that are prevalent in the global decrum's disease market regions and players that will dominate the global trends and lead the decrum's disease market operations towards growth figures that have been predicted by the prominent leaders in the international market and key experts for the ongoing forecast period that ends in 2028.
- To understand the scale of functioning of the global decrum's disease market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services.
- To draw a competitive scale amongst the global decrum's disease market players and to understand the recent developments of the key decrum's disease market players in the recent past that promise great results to the market for the ongoing forecast period and automotive refinishcoating market trends that end in 2028.
Segment Overview:
The decrum's disease market has been segmented as follows:
By treatment
- Surgery
- Medication
- Liposuction
- Electrotherapy
- Acupuncture
- others
By distribution channel,
- retail pharmacies
- hospital pharmacies
- By end-user
- hospital & clinics
- ambulatory surgical centers
- others
By Region
North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
Asia-Pacific
- Japan
- China
- Australia
- India
LAMEA
- Brazil
- Saudi Arabia
- South Africa
Regional Analysis:
The global decrum's disease market has been divided into four regions where each region has been contributing significantly in terms of its capabilities and population demands. However, among the four regions, the Asia Pacific region has been accounting for the major decrum's disease treatment market share whereby the key drivers towards the growth of the decrum's disease treatment industry are developed here since a variety of researches taking place in these countries and continuous investment being made towards the growth of the health sector.
The major decrum's disease treatment market revenue is expected to come from countries like China, Japan, Korea, and India. The decrum's disease statistics indicate that the population along with the disposable incomes of people of these countries has been increasing which has led to shifts in lifestyles and changing demands. The shift of the people towards health awareness has contributed towards the growth of the market in this region.
The European region has also been experiencing major growth with contributions coming from developed nations such as France, Germany, Denmark, Belgium, etc. due to the increased expenditure made by the Governments of these countries towards research and developments in the health sector. The North American region is also experiencing vast growth in decrum's disease treatment market as the countries in this region have been reaping the benefits of technology thereby maximizing the level of operations and reducing operational costs and also the people in these countries have also generated awareness regarding the decorum’s disease.
Competitive Landscape:
The competitive landscape in terms of the decrum's disease market has been immense and nail-biting with new players easily entering the market and the existing players making huge investments in this segment.
- AbbVie Inc.
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Novartis AG
- Hoffmann La Roche Ltd.
- Bausch Health Companies Inc.
- AstraZeneca
- Eli Lilly and Company
- Sanofi
- Amgen Inc.
The key players in the market are more focused on developing future strategies and set themselves as joint ventures to increase the decrum's disease market share and size.
Recent Developments:
Recently, Raziel Therapeutics, a pharmaceutical company has announced its agreement with Fosun Pharma, a leading pharmaceutical company in china for licensing of disrupting technology of RZL 012 which is analyzed to be one such drug to cure the decrum’s disease. This would boost the market for both companies.
Earlier this year, the Israeli VC firm Pontifax along with Catalyst funds, Quark ventures, and Peregrine ventures provided funds to the pharmaceutical company Raziel therapeutics for its development of the drug to be used as a cure for the decrum’s disease.
Report Overview:
The Global report helps the investors to gain meaningful information about the decrum's disease treatment market and make decisions wisely. The report discusses the steps taken by the decrum's disease market leaders to boost the market growth and inflate market valuation for their good. The report fully summarises the ongoing market scenario in the decrum's disease market which would help the intended audience to seek more information about the market. The objective of the report was to fully summarise the key players in the market and their role in boosting the decrum's disease market value. The report also discusses the future growth prospects and the competitive landscape in the decrum's disease treatment industry and lays down the expected growth rate of the market along with the hindrances it may face.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant value |
| CAGR | 2020–2027: Substantial CAGR |
| Base Year | 2019 |
| Forecast Period | 2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | By Treatment, By Distribution Channel, By End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. |
| Key Market Opportunities |
|
| Key Market Drivers | Growing healthcare expenditures in the developed as well as developing economies |
Frequently Asked Questions (FAQ) :
The major factor to impact dercum disease market is lack of awareness.
Developing economies, surge in occurrences of lipomas, and increasing funding for research and development activities would ensure better dercum disease market growth.
Dercum disease market report has end users like ambulatory surgical centers, hospital & clinics, and others.
The distribution channel includes hospital pharmacies, retail pharmacies, and others for the study of dercum disease market.
The report has treatments like acupuncture, medication, surgery, electrotherapy, liposuction, and others.
